mFOLFOX Versus mFOLFIRI Versus FOLFPTX as First-line Treatment in AGC or EGJA

NCT03045770 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

OTHER_GOV

Sponsor class

Conditions

Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction

Interventions

DRUG: Fluorouracil
DRUG: Oxaliplatin
DRUG: Irinotecan
DRUG: Paclitaxel
DRUG: calcium levofolinate

Sponsor

Fujian Cancer Hospital